DAMPs, PAMPs và alarmins: tất cả những gì chúng ta cần biết về sự nguy hiểm

Janeway, 2002, Innate immune recognition, Annu. Rev. Immunol., 20, 197, 10.1146/annurev.immunol.20.083001.084359

Agresti, 2003, HMGB proteins and gene expression, Curr. Opin. Genet. Dev., 13, 170, 10.1016/S0959-437X(03)00023-6

Müller, 2004, Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function, J. Intern. Med., 255, 332, 10.1111/j.1365-2796.2003.01296.x

Scaffidi, 2002, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, 418, 191, 10.1038/nature00858

Gardella, 2002, The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway, EMBO Rep., 3, 995, 10.1093/embo-reports/kvf198

Bonaldi, 2003, Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion, EMBO J., 22, 5551, 10.1093/emboj/cdg516

Semino, 2007, The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion, J. Leukoc. Biol., 81, 92, 10.1189/jlb.0306172

Rauvala, 1988, The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons, J. Cell Biol., 107, 2293, 10.1083/jcb.107.6.2293

Liu, 2006, HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers, Am. J. Physiol. Cell Physiol., 290, C990, 10.1152/ajpcell.00308.2005

Porto, 2006, Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to High Mobility Protein Box 1, FASEB J., 20, E1, 10.1096/fj.06-5867fje

Wahamaa, 2007, HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay, J. Leukoc. Biol., 81, 129, 10.1189/jlb.0506349

Ito, 2007, Cytolytic cells induce HMGB1 release from melanoma cell lines, J. Leukoc. Biol., 81, 75, 10.1189/jlb.0306169

Qin, 2006, Role of HMGB1 in apoptosis-mediated sepsis lethality, J. Exp. Med., 203, 1637, 10.1084/jem.20052203

Dumitriu, 2005, HMGB1: guiding immunity from within, Trends Immunol., 26, 381, 10.1016/j.it.2005.04.009

Yang, 2006, High mobility group box-1 (HMGB1) protein induces the migration and activation of human dendritic cells and acts as an alarmin, J. Leukoc. Biol., 81, 59, 10.1189/jlb.0306180

Dumitriu, 2007, The secretion of HMGB1 is required for the migration of maturing dendritic cells, J. Leuk. Biol., 81, 84, 10.1189/jlb.0306171

Degryse, 2001, The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells, J. Cell Biol., 152, 1197, 10.1083/jcb.152.6.1197

Sappington, 2002, HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice, Gastroenterology, 123, 790, 10.1053/gast.2002.35391

Mitola, 2006, Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine, J. Immunol., 176, 12, 10.4049/jimmunol.176.1.12

Dumitriu, 2005, Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells, Eur. J. Immunol., 35, 2184, 10.1002/eji.200526066

Rovere-Querini, 2004, HMGB1 is an endogenous immune adjuvant released by necrotic cells, EMBO Rep., 5, 825, 10.1038/sj.embor.7400205

Messmer, 2004, High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization, J. Immunol., 173, 307, 10.4049/jimmunol.173.1.307

Palumbo, 2004, Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation, J. Cell Biol., 164, 441, 10.1083/jcb.200304135

Limana, 2005, Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation, Circ. Res., 97, e73, 10.1161/01.RES.0000186276.06104.04

Germani, 2006, Pivotal Advance: High-mobility group box 1 protein—a cytokine with a role in cardiac repair, J. Leukoc. Biol, 81, 41, 10.1189/jlb.0306165

Hori, 1995, The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin, J. Biol. Chem., 270, 25752, 10.1074/jbc.270.43.25752

Andersson, 2000, High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes, J. Exp. Med., 192, 565, 10.1084/jem.192.4.565

Erlandsson-Harris, 2006, Alarmin(g) news about danger. Workshop on Innate Danger Signals and HMGB1, EMBO Rep., 7, 774, 10.1038/sj.embor.7400759

Rouhiainen, 2006, Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (Amphoterin), J. Leukoc. Biol., 81, 49, 10.1189/jlb.0306200

Park, 2004, Involvement of TLR2 and TLR4 in cellular activation by high mobility group box 1 protein (HMGB1), J. Biol. Chem., 279, 7370, 10.1074/jbc.M306793200

Foell, 2007, S100 proteins expressed in phagocytes: a novel group of Damage Associated Molecular Pattern molecules, J. Leukoc. Biol, 81, 28, 10.1189/jlb.0306170

Bianchi, 2006, S100B binding to RAGE in microglia stimulates COX-2 expression, J. Leukoc. Biol., 81, 108, 10.1189/jlb.0306198

Zhou, 2004, Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus, J. Biol. Chem., 279, 27320, 10.1074/jbc.M308650200

Schmitt, 2007, Intracellular and extracellular functions of Heat Shock Proteins: Repercussions in cancer therapy, J. Leukoc. Biol., 81, 15, 10.1189/jlb.0306167

Werman, 2004, The precursor form of IL-1α is an intracrine proinflammatory activator of transcription, Proc. Natl. Acad. Sci. USA, 101, 2434, 10.1073/pnas.0308705101

Shi, 2003, Molecular identification of a danger signal that alerts the immune system to dying cells, Nature, 425, 516, 10.1038/nature01991

Shi, 2006, Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model, J. Immunol., 176, 3905, 10.4049/jimmunol.176.7.3905

Martinon, 2006, Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, 440, 237, 10.1038/nature04516

Bierhaus, 2005, Understanding RAGE, the receptor for advanced glycation end products, J. Mol. Med., 83, 876, 10.1007/s00109-005-0688-7

Salmivirta, 1992, Neurite growth-promoting protein (amphoterin, p30) binds syndecan, Exp. Cell Res., 200, 444, 10.1016/0014-4827(92)90194-D

Tsung, 2007, Increasing numbers of hepatic dendritic cells promote HMGB1 mediated ischemia-reperfusion injury, J. Leukoc. Biol., 81, 119, 10.1189/jlb.0706468

Abeyama, 2005, The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism, J. Clin. Invest., 115, 1267, 10.1172/JCI22782

Urbonaviciute, 2007, Factors masking HMGB1 in human serum and plasma, J. Leukoc. Biol., 81, 67, 10.1189/jlb.0306196

Yang, 2004, Reversing established sepsis with antagonists of endogenous high-mobility group box 1, Proc. Natl. Acad. Sci. USA, 101, 296, 10.1073/pnas.2434651100

Taniguchi, 2003, High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine, Arthritis Rheum., 48, 971, 10.1002/art.10859

Kokkola, 2003, Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity, Arthritis Rheum., 48, 2052, 10.1002/art.11161

Popovic, 2005, Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus, Arthritis Rheum., 52, 3639, 10.1002/art.21398

Taguchi, 2000, Blockage of RAGE-amphoterin signalling suppresses tumour growth and metastasis, Nature, 405, 354, 10.1038/35012626

Sitia, 2007, Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice, J. Leukoc. Biol., 81, 100, 10.1189/jlb.0306173

Zenz, 2005, Psoriasislike skin disease and arthritis caused by inducible epidermal deletion of Jun proteins, Nature, 437, 369, 10.1038/nature03963

Oppenheim, 2005, Alarmins: chemotactic activators of immune responses, Curr. Opin. Immunol., 17, 359, 10.1016/j.coi.2005.06.002

Liu, 2005, Galectins as modulators of tumour progression, Nat. Rev. Cancer, 5, 29, 10.1038/nrc1527

Goldstein, 2005, Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues, Trends Mol. Med., 11, 421, 10.1016/j.molmed.2005.07.004

Christian, 2003, Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels, J. Cell Biol., 163, 871, 10.1083/jcb.200304132

Gerke, 2005, Annexins: linking Ca2+ signalling to membrane dynamics, Nat. Rev. Mol. Cell Biol., 6, 449, 10.1038/nrm1661

Munoz, 2006, The influence on the immunomodulatory effects of dying and dead cells of Annexin V, J. Leukoc. Biol., 81, 6, 10.1189/jlb.0306166

Bianchi, 2004, Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death, Trends Cell Biol., 14, 287, 10.1016/j.tcb.2004.04.004

Seong, 2004, Hydrophobicity: an ancient damageassociated molecular pattern that initiates innate immune responses, Nat. Rev. Immunol., 4, 469, 10.1038/nri1372